Redwood Scientific Technologies, Inc.

FRC's fair value estimate for Redwood Scientific Technologies, Inc., and the rating behind it. RSCI last traded at $0.01; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Redwood Scientific Technologies, Inc.. Starting points for Redwood Scientific Technologies, Inc.: EPS -$0.02, beta -4.29 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Redwood Scientific Technologies, Inc.. Redwood Scientific Technologies, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Redwood Scientific Technologies, Inc.. Trailing twelve-month EPS for Redwood Scientific Technologies, Inc. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Redwood Scientific Technologies, Inc.. Redwood Scientific Technologies, Inc. has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Redwood Scientific Technologies, Inc. valued side by side against its closest peers. Redwood Scientific Technologies, Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Redwood Scientific Technologies, Inc., and how their positions are changing. At a $1,872 market value, institutional positions materially move Redwood Scientific Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Redwood Scientific Technologies, Inc. executives and directors. Shares of Redwood Scientific Technologies, Inc. have traded between $0.0002 and $0.24 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Redwood Scientific Technologies, Inc.. Redwood Scientific Technologies, Inc. is a $1,872 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Redwood Scientific Technologies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Redwood Scientific Technologies, Inc.. Coverage tracks Redwood Scientific Technologies, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.